Cargando…
Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
BACKGROUND: We investigated whether and to what extent the ratio between circulating fibrinogen (Fg) and its degradation products (FDP) reflects the severity of coronary artery disease (CAD) in type 2 diabetic patients. METHODS: Plasma levels of Fg and FDP were determined, and Fg/FDP ratio was calcu...
Autores principales: | Xiong, Wei-Xin, Shen, Ying, Dai, Dao-Peng, Lu, Lin, Zhang, Qi, Zhang, Rui-Yan, Shen, Wei-Feng, Tao, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833973/ https://www.ncbi.nlm.nih.gov/pubmed/25758263 http://dx.doi.org/10.4103/0366-6999.152465 |
Ejemplares similares
-
The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
por: Kołodziejczyk, Joanna, et al.
Publicado: (2013) -
CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
por: Wang, Chunxu, et al.
Publicado: (2022) -
Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020) -
Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
por: Wen, Tingting, et al.
Publicado: (2023) -
Fibrin(ogen) mediates acute inflammatory responses to biomaterials
Publicado: (1993)